Login / Signup

Beyond Survival: The US Food and Drug Administration Confirms Surrogate End Points for Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy.

Courtney D D DiNardoDaniel A Pollyea
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keyphrases
  • newly diagnosed
  • drug administration
  • acute myeloid leukemia
  • locally advanced
  • allogeneic hematopoietic stem cell transplantation
  • free survival
  • human health
  • squamous cell carcinoma
  • radiation therapy
  • rectal cancer